Tumor–stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models

[1]  P Giraud,et al.  Chapter 44 – Non–Small Cell Lung Cancer , 2016 .

[2]  D. Lacey,et al.  Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.

[3]  F. Lecanda,et al.  Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer , 2010, Oncogene.

[4]  J. Rhodes,et al.  Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. , 2009, Cancer research.

[5]  L. Matrisian,et al.  Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. , 2009, Cancer research.

[6]  W. Holzgreve,et al.  Genes controlling spread of breast cancer to lung "gang of 4". , 2008, Experimental oncology.

[7]  Javier De Las Rivas,et al.  A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. , 2008, Cancer research.

[8]  J. Kurie,et al.  A genetic mouse model for metastatic lung cancer with gender differences in survival , 2007, Oncogene.

[9]  J. Massagué,et al.  Genetic determinants of cancer metastasis , 2007, Nature Reviews Genetics.

[10]  M. Doucet,et al.  TGF‐β Promotes the Establishment of Renal Cell Carcinoma Bone Metastasis , 2006 .

[11]  J. Chirgwin,et al.  Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. , 2005, Cancer research.

[12]  T. Jacks,et al.  The differential effects of mutant p53 alleles on advanced murine lung cancer. , 2005, Cancer research.

[13]  C. Savage-Dunn,et al.  TGF-beta signaling. , 2005, WormBook : the online review of C. elegans biology.

[14]  G. Oster,et al.  The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer , 2005, Oncology.

[15]  K. Hunter,et al.  Modeling metastasis in vivo. , 2004, Carcinogenesis.

[16]  I. Jurisica,et al.  Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis , 2004, Oncogene.

[17]  M. Waltham,et al.  Pro-Matrix Metalloproteinase-2 Transfection Increases Orthotopic Primary Growth and Experimental Metastasis of MDA-MB-231 Human Breast Cancer Cells in Nude Mice , 2004, Cancer Research.

[18]  R. Herbst,et al.  Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[20]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[21]  Yusuke Nakamura,et al.  Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. , 2003, Molecular cancer research : MCR.

[22]  L. Suva,et al.  Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. , 2002, Cancer research.

[23]  J. Chirgwin,et al.  Transforming Growth Factor-Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways * , 2002 .

[24]  E. Ogata,et al.  Involvement of parathyroid hormone–related protein in experimental cachexia induced by a human lung cancer–derived cell line established from a bone metastasis specimen , 2001, International journal of cancer.

[25]  G D Roodman,et al.  Biology of osteoclast activation in cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Shih,et al.  Global analysis of gene expression in invasion by a lung cancer model. , 2001, Cancer research.

[27]  G. Roodman,et al.  Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.

[28]  I. Saiki,et al.  Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer. , 2000, Neoplasia.

[29]  T. Jacks,et al.  Modeling human lung cancer in mice: similarities and shortcomings , 1999, Oncogene.

[30]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[31]  H. Shimada,et al.  Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. , 1998, Cancer research.

[32]  R. Coleman Skeletal complications of malignancy , 1997, Cancer.

[33]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[34]  Yukiko Ozawa,et al.  An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. , 1996, Cancer research.

[35]  J. Minna,et al.  Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.

[36]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[37]  F. Lecanda,et al.  PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. , 2011, Cancer research.

[38]  M. Doucet,et al.  TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  K. Kelly,et al.  Mechanisms of cancer metastasis to the bone , 2005, Cell Research.

[40]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[41]  J. Chirgwin,et al.  Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. , 2002, The Journal of biological chemistry.

[42]  G. Roodman,et al.  Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.

[43]  M. Noda,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteopontin Facilitates Angiogenesis, Accumulation of , 2000 .

[44]  S. Steinberg,et al.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. , 1992, Oncogene.